Overview


Recognising the role of diagnostics in the community Doris-Ann Williams MBE – Chief Executive, British In Vitro Diagnostics Association


Welcome to this latest issue of The Biomedical Science Industry Handbook for 2023. At BIVDA, we are excited by the prospects for diagnostics this coming year as we move forward into an era where, although societal challenges are enormous, the role of diagnostics has been recognised; with a specific strategy being written by DHSC in the second half of 2022. And while within the NHS and Government the term ‘diagnostics’ covers much more than IVDs and imaging is often at the front of people’s minds when considering diagnostics; nonetheless the role of laboratory medicine is key to the Government’s goals of tackling the pandemic backlog, achieving early diagnosis and preventing disease where possible.


Using the impetus of the pandemic and


recent innovation to do more testing in the community is also a key focus which requires the support of the local pathology service to ensure it is successful. Policy is also being developed around ‘diagnostics at home’, building on the engagement and knowledge among the public from self- testing for COVID and the realisation that people could triage their own


Using the impetus of the pandemic and recent innovation to do more testing in the community is a key focus


THE BIOMEDICAL SCIENCE INDUSTRY HANDBOOK 2023 l 9


symptoms if they have the right tests to do so. This would be suitable for conditions like


respiratory infections; when seeing a GP may not be required and isolating people may help prevent spread of disease. This will need the right sort of tests, with ease of use equal to performance to ensure correct results. But naturally the role of actual laboratory


testing remains paramount; the symbiotic relationship between industry suppliers and the end customers using our tests and technology remains at least as important as ever before. So I wish every success to all the readers of this handbook for 2023, along with a good helping of perseverance to carry on while conditions remain difficult and so much is uncertain for both industry and for the biomedical science profession.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80